About
ABCDx SA is a Swiss medtech company based in Geneva, specializing in the development of point-of-care diagnostic tools for brain injuries, including traumatic brain injury (TBI) and stroke. Founded as a spinoff from the University of Geneva and Vall d’Hebron University Hospital, ABCDx aims to enhance brain injury care by providing rapid and accurate diagnostics directly at the point of care, such as in emergency departments or on-site during incidents. The company offers a range of diagnostic tools, including its flagship product, TBI Check, a blood test for detecting mild traumatic brain injuries. Another key product, LVOCheck, is designed to identify large vessel occlusion strokes using a finger-prick blood sample, delivering results in just 15 minutes. ABCDx's technology platform also includes a proprietary Software as a Medical Device (SaMD) that supports these biomarker-based diagnostics, assisting healthcare professionals in making timely treatment decisions while reducing the need for costly imaging procedures.
Technologies
Keywords
Company Information
-
Employees 11
-
Founded 2014
-
Total Funding $108173
Location
Barcelona, Catalonia, Spain